Dermatophytosis

• FDA approval · 2014-01-09
  FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC via an Original Application.

• FDA approval · 2013-01-03
  FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)

  FDA approves a supplemental application for ketoconazole submitted by Thirty Madison Inc (ANDA076942).

• FDA approval · 2011-08-25
  FDA Approved: KETOCONAZOLE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved Padagis Israel Pharmaceuticals Ltd's Ketoconazole original application (ANDA 091550) for a generic ketoconazole product.

• FDA approval · 2011-02-04
  FDA Approved: KETOCONAZOLE — Supplemental Application (Northstar Rx LLC)

  The FDA approved a supplemental application for Ketoconazole submitted by Northstar Rx LLC.

• FDA approval · 2009-03-18
  FDA Approved: KETOCONAZOLE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

  FDA approved a supplemental ANDA for Ketoconazole, a generic antifungal product from E. Fougera & Co. (division of Fougera Pharmaceuticals).

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-02-20
  Clinical Trial Update: The Efficacy of Pulsed Dye Laser in Dermatophytosis [Phase 1]

  Phase 1 trial evaluating the efficacy of pulsed dye laser for cutaneous dermatophytosis has been completed.

• FDA approval · 2007-09-10
  FDA Approved: CLOTRIMAZOLE — Supplemental Application (Padagis US LLC)

  FDA approved a supplemental application for clotrimazole by Padagis US LLC.

• FDA approval · 2007-09-10
  FDA Approved: GRISOFULVIN — Original Application (Cipla USA Inc.)

  FDA approved Cipla USA Inc.'s original application for griseofulvin, a generic antifungal, enabling its marketing.

• FDA approval · 2007-07-02
  FDA Approved: TERBINAFINE — Original Application (Cipla USA Inc.)

  FDA approved Cipla USA Inc.'s original application for generic terbinafine, expanding access to treatment for fungal infections such as nail…